An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation
augmented reality
Treatment Study
Summary
Study start date: June 1, 2023
Actual date on which the first participant was enrolled.The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Inclusion Criteria: * ages18 and older * acute stroke * admitted to inpatient rehabilitation * presence of neglect (Behavioral Inattention Test total score \<129, or scoring below pre-defined cutoff score in at least one of the six subtests) * more than 10/% missed targets on the Augmented Reality Screening Test * intact vibration (positive test on Vibration Sensation Test) * intact auditory function (positive test on Auditory Sensation Test) * English speaking Exclusion Criteria: * inability to follow one-step directions at least 80% of the time * current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor * metal in the head that causes interference with the EEG system * self-report of previous positive photic stimulation test
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Northeastern University
Boston, United States